Stress-resistant Translation of Cathepsin L mRNA in Breast Cancer Progression

Autor: Tholen, Martina ^{‡, §}, Wolanski, Julia ^‡, Stolze, Britta ^‡, Chiabudini, Marco ^{¶, ‖}, Gajda, Mieczyslaw ^**, Bronsert, Peter ^{‡‡, §§}, Stickeler, Elmar ^{§§, ¶¶}, Rospert, Sabine ^{¶, ‖}, Reinheckel, Thomas ^{‡, ‖, §§, 1}

Publikováno v: In Journal of Biological Chemistry 19 June 2015 290(25):15758-15769

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Comprehensive analysis of the ErbB receptor family in pediatric nervous system tumors and rhabdomyosarcoma.

Autor: Varlet P; GHU Psychiatrie et Neurosciences, site Sainte-Anne, service de Neuropathologie, Paris, France., Bouffet E; The Hospital for Sick Children, Toronto, Ontario, Canada., Casanova M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Giangaspero F; Università Roma Sapienza, Rome, Italy.; IRCCS Neuromed, Pozzilli, Italy., Antonelli M; Università Roma Sapienza, Rome, Italy., Hargrave D; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK., Ladenstein R; Department of Paediatrics, St. Anna Children's Cancer Research Institute, Medical University, Vienna, Austria., Pearson A; Paediatric Drug Development, Children and Young People's Unit, Royal Marsden Hospital, London, UK.; Division of Clinical Studies, Institute of Cancer Research, London, UK., Hawkins C; The Hospital for Sick Children, Toronto, Ontario, Canada., König FB; Targos Molecular Pathology GmbH, Kassel, Germany., Rüschoff J; Targos Molecular Pathology GmbH, Kassel, Germany., Schmauch C; Targos Molecular Pathology GmbH, Kassel, Germany., Bühnemann C; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Garin-Chesa P; Staburo GmbH, Munich, Germany, on behalf of Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Schweifer N; Staburo GmbH, Munich, Germany, on behalf of Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Uttenreuther-Fischer M; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Gibson N; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Ittrich C; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Krämer N; Staburo GmbH, Munich, Germany, on behalf of Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Solca F; Boehringer Ingelheim RCV GmbH & Co. KG, Vienna, Austria., Stolze B; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Geoerger B; Gustave Roussy Cancer Center, Department of Pediatric and Adolescent Oncology, INSERM U1015, Université Paris Saclay, Villejuif, France.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2022 Jan; Vol. 69 (1), pp. e29316. Date of Electronic Publication: 2021 Sep 21.